An endogenous neuroprotectant substance, 1-methyl-1,2,3,4- tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats

Journal of Neural Transmission

Volumn 114, Issue 3, 2007, Pages 307-317

  Antkiewicz Michaluk, L ^a   Filip, M ^a   Michaluk, J ^a   Romanska I ^a   Przegalinski E ^a   Vetulani, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Cocaine reinstatement; Cocaine self administration; Metabolism of monoamines; Rat brain structures

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; NORADRENALIN; SEROTONIN; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DOPAMINE METABOLISM; DRUG ABUSE; DRUG EFFECT; DRUG INHIBITION; DRUG SELF ADMINISTRATION; FRONTAL CORTEX; MALE; NERVE ENDING; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; REWARD; SEROTONIN METABOLISM; VENTRAL TEGMENTUM; WHITE MATTER; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; LIMBIC SYSTEM; MALE; NEURAL PATHWAYS; NEUROPROTECTIVE AGENTS; NOREPINEPHRINE; RATS; RECURRENCE; REWARD; SELF ADMINISTRATION; SEROTONIN; SUBSTANCE WITHDRAWAL SYNDROME; TETRAHYDROISOQUINOLINES; VENTRAL TEGMENTAL AREA;

EID: 33847309588     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0546-y     Document Type: Article

References (59)

1. K Abe T Saitoh Y Horiguchi I Utsunomiya K Taguchi 2005 Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease Biol Pharm Bull 28 1355 1362
2. L Antkiewicz-Michaluk J Michaluk I Romańska I Papla J Vetulani 2000 Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol J Neural Transm 107 1009 1019
3. L Antkiewicz-Michaluk J Michaluk M Mokrosz I Romańska E Lorenc-Koci S Ohta J Vetulani 2001 Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties J Neurochem 78 100 108
4. L Antkiewicz-Michaluk B Karolewicz I Romańska J Michaluk A Bojarski J Vetulani 2003 1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain Eur J Pharmacol 466 263 269
5. L Antkiewicz-Michaluk J Wardas J Michaluk I Romańska A Bojarski J Vetulani 2004 Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone Int J Neuropsychopharmacol 7 155 163
6. L Antkiewicz-Michaluk M Filip J Michaluk I Romańska A Patsenka I Papla E Przegaliński J Vetulani 2005 Conditioned rewarding stimulus associated with cocaine self-administration reverses the depression of catecholamine brain systems following cocaine withdrawal in rats Int J Neuropsychopharmacol 9 37 50
7. L Antkiewicz-Michaluk M Filip W Kostowski A Patsenka P Popik E Przegaliński M Wróbel 2005a 1-Methyl-1,2,3,4- tetrahydroisoquinoline attenuates ethanol, cocaine and morphine addiction in behavioral models: neurochemical correlates Acta Neurobiol Exp 65 P3.01 pp 321
8. A Ayala J Parrado J Cano A Machado 1994 Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat Brain Res 638 334 336
9. DA Baker LTL Tran-Nguyen RA Fuchs JL Neisewander 2001 Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats Psychopharmacology 155 18 26
10. SP Berger S Hall JD Mickalian MS Reid CA Crawford K Delucchi K Carr S Hall 1996 Haloperidol antagonism of cue-elicited cocaine craving Lancet 347 504 508
11. MA Bozarth 1989 New perspectives on cocaine addiction: recent findings from animal research Can J Physiol Pharmacol 67 1158 1167
12. G Campiani S Butini F Trotta C Fattorusso B Catalanotti F Aiello S Gemma V Nacci E Novellino JA Stark A Cagnotto E Fumagalli F Carnovali L Cervo T Mennini 2003 Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors J Med Chem 46 3822 3839
13. KM Carroll BJ Rounsaville C Nich LT Gordon PW Wirtz F Gawin 1994 One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects Arch Gen Psychiatry 51 989 997
14. C Contoreggi RI Herning B Koeppl PM Simpson PJ Negro Jr C Fortner-Burton J Hess 2003 Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion Neuroendocrinology 78 154 162
15. JL Cornish PW Kalivas 2000 Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction J Neurosci 20 RC89
16. CA Dackis MS Gold DR Sweeney JP Byron Jr R Climko 1987 Single-dose bromicriptine reverses cocaine craving Psychiatry Res 20 261 264
17. 2 receptors in cocaine self-administration and seeking behavior in rats Pharmacol Rep 57 35 48
18. RA Fuchs LTL Tran-Nguyen SE Specio RS Groff JL Neisewander 1998 Predictive validity of the extinction/reinstatement model of drug craving Psychopharmacology 135 151 160
19. FH Gawin 1991 Cocaine addiction: psychology and neurophysiology Science 251 1580 1586
20. FJ Garcia-Ladona BF Cox 2003 BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction CNS Drug Rev 9 141 158
21. MB Ghasemzadeh LK Permenter R Lake PF Worley PW Kalivas 2003 Homer1 proteins and AMPA receptors modulate cocaine-induced behavioural plasticity Eur J Neurosci 18 1645 1651
22. NE Goeders 2002 Stress and cocaine addiction J Pharmacol Exp Ther 301 785 789
23. RZ Goldstein ND Volkow 2002 Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex Am J Psychiatry 159 1642 1652
24. JW Grimm L Lu T Hayashi BT Hope TP Su Y Shaham 2003 Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving J Neurosci 23 742 747
25. L Hadelsman A Rosenblum M Palij S Magura J Foote M Lovejoy B Stimmel 1997 Bromocriptine for cocaine dependence. A controlled clinical Trial Am J Addict 6 54 64
26. M Kohno S Ohta M Hirobe 1986 Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain Biochem Biophys Res Commun 140 448 454
27. B Le Foll JC Schwartz P Sokoloff 2000 Dopamine D3 receptor agents as potential new medications for drug addiction Eur Psychiatry 15 140 146
28. B Le Foll SR Goldberg P Sokoloff 2005 The dopamine D3 receptor and drug dependence: effects on reward or beyond? Neuropharmacology 49 525 541
29. KY Little UN Patel TB Clark JD Butts 1996 Alteration of brain dopamine and serotonin levels in cocaine users: a preliminary report Am J Psychiatry 153 1216 1218
30. J Littleton 2000 Can craving be modeled in animals? The relapse prevention perspective Addiction 95 Suppl 2 S83 S90
31. E Lorenc-Koci M Smialowska L Antkiewicz-Michaluk K Golembiowska M Bajkowska S Wolfarth 2000 Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats Neuroscience 95 1049 1059
32. E Lorenc-Koci J Wojcikowski M Kot A Haduch J Boksa WA Daniel 2004 Disposition of 1,2,3,4,-tetrahydroisoquinoline in the brain of male Wistar and Dark Agouti rats Brain Res 996 168 179
33. 3 receptor ligands Chembiochem 5 508 518
34. A Markou F Weiss LH Gold SB Caine G Schulteis GF Koob 1993 Animal models of drug craving Psychopharmacology 112 163 182
35. J Michaluk A Krygowska-Wajs B Karolewicz L Antkiewicz-Michaluk 2002 Role of noradrenergic system in the mechanism of action of endogenous neurotoxin 1,2,3,4-tetrahydroisoquinoline: biochemical and functional studies Pol J Pharmacol 54 19 25
36. 1 receptors in rhesus monkeys Synapse 28 1 9
37. 2 receptors in rhesus monkeys Synapse 30 88 96
38. WA Morton 1999 Cocaine and Psychiatric Symptoms Prim Care Companion J Clin Psychiatry 1 109 113
39. EV Nunes FR Levin 2004 Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis JAMA 291 1887 1896
40. T Origitano J Hannigan MA Collins 1981 Rat brain salsolinol and blood-brain barrier Brain Res 224 446 451
41. A Patsenka L Antkiewicz-Michaluk 2004 Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydroisoquinoline alkaloids Pol J Pharmacol 56 727 734
42. A Patsenka K Golembiowska E Ziemińska E Salińska J Lazarewicz A Wa̧sik J Michaluk L Antkiewicz-Michaluk 2004 Neuroprotective effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline: in vitro and in vivo studies in rats Pol J Pharmacol 56 Suppl 179
43. 3 receptor agonist Nature 400 371 375
44. KL Preston JT Sullivan EC Strain GE Bigelow 1992 Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers J Pharmacol Exp Ther 262 279 291
45. A Preti 2000 BP-897 Bioproject Curr Opin Investig Drugs 1 110 115
46. R Ranaldi DC Roberts 1996 Initiation, maintenance and extinction of cocaine self-administration with and without conditioned reward Psychopharmacology 128 89 96
47. R Reeves M Thiruchelvam DA Cory-Slechta 2004 Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists Brain Res 1008 155 167
48. ZL Rossetti Y Hmaidan GL Gessa 1992 Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats Eur J Pharmacol 221 227 234
49. DA Smelson J Williams D Ziedonis BD Sussner MF Losonczy C Engelhart M Kaune 2004 A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients J Subst Abuse Treat 27 45 49
50. I Stolerman 1992 Drugs of abuse: behavioural principles, methods and terms Trends Pharmacol Sci 13 170 176
51. DW Teller P Devenyi 1988 Bromocriptine in cocaine withdrawal - does it work? Int J Addict 23 1197 1205
52. J Vetulani 2001 Drug addiction. Part II. Neurobiology of addiction (Review) Pol J Pharmacol 53 303 317
53. J Vetulani L Antkiewicz-Michaluk I Nalepa M Sansone 2003 A possible physiological role for cerebral tetrahydroisoquinolines Neurotox Res 5 147 155
54. T Watanabe T Nakagawa R Yamamoto A Maeda M Minami M Satoh 2002 Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats Jpn J Pharmacol 88 399 406
55. A Wa̧sik A Patsenka L Antkiewicz-Michaluk 2005 An endogenous compound 1-methyl-1,2,3,4-tetrahydroisoquinoline prevents the morphine addiction in rat: the view on neurochemical mechanism of action Eur Neuropsychopharmacol 15 Suppl 22 23
56. F Weiss R Ciccocioppo LH Parsons S Katner X Liu EP Zorrilla GR Valdez O Ben-Shahar S Angeletti RR Richter 2001 Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors Ann NY Acad Sci 937 1 26
57. WL Woolverton KM Johnson 1992 Neurobiology of cocaine abuse Trends Pharmacol Sci 13 193 200
58. T Yamakawa Y Kotake M Fujitani H Shintani Y Makino S Ohta 1999 Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain Neurosci Lett 276 68 70
59. H Zhu GA Barr 2004 The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats Int J Dev Neurosci 22 379 395